CYP2C9 polymorphisms and CYP2C9*2 genotyping primers.
- Published in:
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 4, p. 409, doi. 10.1046/j.1365-2125.2002.01572_7.x
- Publication type:
- Article
Works matching IS 03065251 AND DT 2002 AND VI 53 AND IP 4
Results: 22
1
2
CYP2C9 polymorphism and warfarin dose requirements.
- Published in:
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 4, p. 408, doi. 10.1046/j.1365-2125.2002.01572_6.x
- Publication type:
- Article
3
β-adrenoceptor blockers and serotonin.
- Published in:
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 4, p. 407, doi. 10.1046/j.1365-2125.2002.01572_4.x
- Publication type:
- Article
4
Amlodipine and grapefruit juice.
- Published in:
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 4, p. 405, doi. 10.1046/j.1365-2125.2002.01572_3.x
- Publication type:
- Article
5
Syncope following oral chloroquine administration in a hypertensive patient controlled on amlodipine.
- Published in:
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 4, p. 404, doi. 10.1046/j.1365-2125.2002.01572_2.x
- Publication type:
- Article
6
A possible interaction between lithium and rofecoxib.
- Published in:
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 4, p. 403, doi. 10.1046/j.1365-2125.2002.01572_1.x
- Publication type:
- Article
7
Pfizer poster communication prize.
- Published in:
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 4, p. 429P
- Publication type:
- Article
8
POSTER COMMUNICATIONS.
- Published in:
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 4, p. 421P
- Publication type:
- Article
9
GlaxoSmithKline oral communication prize.
- Published in:
- 2002
- Publication type:
- Abstract
10
COMMUNICATIONS.
- Published in:
- 2002
- Publication type:
- Abstract
11
What knowledge and skills are essential for specialists in Clinical Pharmacology and Therapeutics? Results of a Delphi study.
- Published in:
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 4, p. 341, doi. 10.1046/j.1365-2125.2002.01576.x
- By:
- Publication type:
- Article
12
Recombinant protein drugs.
- Published in:
- 2002
- By:
- Publication type:
- Book Review
13
Non-sedating antihistamine drugs and cardiac arrhythmias - biased risk estimates from spontaneous reporting systems?
- Published in:
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 4, p. 370, doi. 10.1046/j.1365-2125.2002.01569.x
- By:
- Publication type:
- Article
14
High persistence of statin use in a Danish population: Compliance study 1993-1998.
- Published in:
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 4, p. 375, doi. 10.1046/j.1365-2125.2002.01563.x
- By:
- Publication type:
- Article
15
Time trends in lipid lowering drug use in The Netherlands. Has the backlog of candidates for treatment been eliminated?
- Published in:
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 4, p. 379, doi. 10.1046/j.1365-2125.2002.01562.x
- By:
- Publication type:
- Article
16
Pharmacokinetics of intravenous busulfan in children prior to stem cell transplantation.
- Published in:
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 4, p. 386, doi. 10.1046/j.1365-2125.2002.01555.x
- By:
- Publication type:
- Article
17
The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide.
- Published in:
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 4, p. 347, doi. 10.1046/j.1365-2125.2002.01554.x
- By:
- Publication type:
- Article
18
Association between antidepressant drug use and hyponatraemia: a case-control study.
- Published in:
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 4, p. 363, doi. 10.1046/j.1365-2125.2002.01550.x
- By:
- Publication type:
- Article
19
Serum cystatin C is not a better marker of creatinine or digoxin clearance than serum creatinine.
- Published in:
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 4, p. 398, doi. 10.1046/j.1365-2125.2002.01549.x
- By:
- Publication type:
- Article
20
Omeprazole hydroxylation is inhibited by a single dose of moclobemide in homozygotic EM genotype for CYP2C19.
- Published in:
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 4, p. 393, doi. 10.1046/j.1365-2125.2002.01366.x
- By:
- Publication type:
- Article
21
Pharmacokinetics and metabolism of oral midazolam in preterm infants.
- Published in:
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 4, p. 390, doi. 10.1046/j.1365-2125.2002.01223.x
- By:
- Publication type:
- Article
22
Pharmacokinetics and pharmacodynamics of tezosentan, an intravenous dual endothelin receptor antagonist, following chronic infusion in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 4, p. 355, doi. 10.1046/j.1365-2125.2002.01158.x
- By:
- Publication type:
- Article